Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Target-induced formation of neuraminidase inhibitors from in vitro virtual combinatorial libraries
2002
Inverting family GH156 sialidases define an unusual catalytic motif for glycosidase action
2019 StandoutNobel
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody
2007
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Isolation of drug-resistant H5N1 virus
2005 Nature
Chronic Inflammation with Increased Human Immunodeficiency Virus (HIV) RNA Expression in the Vaginal Epithelium of HIV‐Infected Thai Women
2001 StandoutNobel
Transforming Growth Factor-β: Activation by Neuraminidase and Role in Highly Pathogenic H5N1 Influenza Pathogenesis
2010
Cancer to bone: a fatal attraction
2011 Standout
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
2011 Standout
Influenza neuraminidase: A druggable target for natural products
2011
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
2006 Standout
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
TGFβ signalling in context
2012 Standout
A G to A transition at the last nucleotide of exon 6 of the γc gene (868G→A) may result in either a splice or missense mutation in patients with X-linked severe combined immunodeficiency
1999
TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
2009 Standout
DNA duplication associated with Charcot-Marie-Tooth disease type 1A
1991 Standout
Determination of Neuraminidase Kinetic Constants Using Whole Influenza Virus Preparations and Correction for Spectroscopic Interference by a Fluorogenic Substrate
2013
Balancing Acts
2004 Standout
Management of Influenza in Households: A Prospective, Randomized Comparison of Oseltamivir Treatment With or Without Postexposure Prophylaxis
2004
Genetic Analysis of Mint/X11 Proteins: Essential Presynaptic Functions of a Neuronal Adaptor Protein Family
2006 StandoutNobel
Trichomonas vaginalis and Tritrichomonas foetus secrete neuraminidase into the culture medium
1989
Neutrophils and immunity: challenges and opportunities
2006 Standout
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
2011 Standout
Rational design of potent sialidase-based inhibitors of influenza virus replication
1993 Nature
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
2020 Standout
Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent Influenza
1999
Antivirals and resistance: influenza virus
2011
The Preterm Prediction Study: Failure of midtrimester cervical sialidase level elevation to predict subsequent spontaneous preterm birth
1999
Intrauterine Infection and Preterm Delivery
2000 Standout
Latent TGF-β structure and activation
2011 Nature
How were new medicines discovered?
2011 Standout
Listening to silence and understanding nonsense: exonic mutations that affect splicing
2002 Standout
Cystic fibrosis genetics: from molecular understanding to clinical application
2014 Standout
Virulence May Determine the Necessary Duration and Dosage of Oseltamivir Treatment for Highly Pathogenic A/Vietnam/1203/04 Influenza Virus in Mice
2005
Suppression of bone formation by osteoclastic expression of semaphorin 4D
2011 Standout
Biodegradation, biodistribution and toxicity of chitosan
2009 Standout
A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response
2016 StandoutNobel
Synthesis and Biological Evaluation of Non‐Hydrolyzable 1,2,3‐Triazole‐Linked Sialic Acid Derivatives as Neuraminidase Inhibitors
2009
A Tripartite Protein Complex with the Potential to Couple Synaptic Vesicle Exocytosis to Cell Adhesion in Brain
1998 StandoutNobel
Points of control in inflammation
2002 StandoutNature
Neurodegenerative diseases and oxidative stress
2004 Standout
N-Glycolylneuraminic Acid as a Receptor for Influenza A Viruses
2019
Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia
1997
Mints as Adaptors
2000 StandoutNobel
Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study
1999
Mints, Munc18-interacting Proteins in Synaptic Vesicle Exocytosis
1997 StandoutNobel
Organic Azides: An Exploding Diversity of a Unique Class of Compounds
2005 Standout
Heritable sclerosing bone disorders
2010
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Lysosomal storage diseases
1995
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells.
1995 StandoutNobel
A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine
2005 Standout
Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment.
1995
Production of Recombinant β-Hexosaminidase A, a Potential Enzyme for Replacement Therapy for Tay-Sachs and Sandhoff Diseases, in the Methylotrophic Yeast Ogataea minuta
2007
Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site: Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza Activity
1997
Sialidases (neuraminidases) in bacterial vaginosis and bacterial vaginosis-associated microflora
1992
Chemical Glycobiology
2001 StandoutScienceNobel
Trichomoniasis
2004 Standout
Visual Involvement in Friedreich's Ataxia and Hereditary Spastic Ataxia
1981
Docking and scoring in virtual screening for drug discovery: methods and applications
2004 Standout
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Dynamic Combinatorial Chemistry
2006 Standout
Genetic linkage and heterogeneity in type I Charcot-Marie-Tooth disease (hereditary motor and sensory neuropathy type I).
1990
The Caenorhabditis elegans mucolipin-like gene cup-5 is essential for viability and regulates lysosomes in multiple cell types
2002 StandoutNobel
Lipoic acid biosynthesis defects
2014
Roles of neuraminidase in the initial stage of influenza virus infection
2006
Mumefural and related HMF derivatives from Japanese apricot fruit juice concentrate show multiple inhibitory effects on pandemic influenza A (H1N1) virus
2010
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Albumin inhibits neutrophil spreading and hydrogen peroxide release by blocking the shedding of CD43 (sialophorin, leukosialin)
1993
Investigation of Neuraminidase-Substrate Recognition Using Molecular Dynamics and Free Energy Calculations
2003
Evoked Potentials in Clinical Medicine
1982 Standout
Protection from Oxidative Stress–Induced Apoptosis in Cortical Neuronal Cultures by Iron Chelators Is Associated with Enhanced DNA Binding of Hypoxia-Inducible Factor-1 and ATF-1/CREB and Increased Expression of Glycolytic Enzymes, p21waf1/cip1, and Erythropoietin
1999 StandoutNobel
The molecular basis of partial penetrance of splicing mutations in cystic fibrosis.
1997
Structure of the lysosomal neuraminidase–β-galactosidase–carboxypeptidase multienzymic complex
1990
Chemical and Biological Strategies for Engineering Cell Surface Glycosylation
2001 StandoutNobel
Clinical and Microbiological Aspects ofTrichomonas vaginalis
1998 Standout
Bisaryloxime Ethers as Potent Inhibitors of Transthyretin Amyloid Fibril Formation
2005 StandoutNobel
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
2012 Standout
The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia.
1996
1 Influenza Virus Sialidase: A Target for Drug Discovery
1999
Hydroxymethylfurfural, A Versatile Platform Chemical Made from Renewable Resources
2013 Standout
Gene in the region of the Friedreich ataxia locus encodes a putative transmembrane protein expressed in the nervous system.
1993
Works of S. Melançon being referenced
More than one mutant allele causes infantile Tay-Sachs disease in French-Canadians.
1990
Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment
2005
An unusual splicing mutation in the HEXB gene is associated with dramatically different phenotypes in patients from different racial backgrounds.
1992
Combined malonic and methylmalonic aciduria: exome sequencing reveals mutations in the ACSF3 gene in patients with a non-classic phenotype
2011
Pyruvate Metabolism in Friedreich's Ataxia
1976
Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-d-N-acetylneuraminate) substrate
1979
Genetic homogeneity at the Friedreich ataxia locus on chromosome 9.
1989